ASAP ID
|
Experiment Description
|
PALAF01
|
wild-type,
standard growth conditions, 1 |
PALAF02
|
wild-type,
standard growth conditions, 2 |
PALAF03
|
wild-type,
standard growth conditions, 3 |
PALAF04
|
wild-type,
standard growth conditions, 4 |
PALAF05
|
wild-type,
standard growth conditions, 5 |
PALAF06
|
acetate, log phase growth, 1 |
PALAF07
|
acetate, log phase growth, 2 |
PALAF08
|
glycerol, log phase growth, 1 |
PALAF09
|
glycerol, log phase growth, 2 |
PALAF10
|
proline, log phase growth, 1 |
PALAF11
|
proline, log phase growth, 2 |
PALAF12
|
late log phase, 90 minutes, 1 |
PALAF13
|
late log phase, 90 minutes, 2 |
PALAF14
|
late log phase, 90 minutes, 3 |
PALAF15
|
stationary phase, 135 minutes, 1 |
PALAF16
|
stationary phase, 135 minutes, 2 |
PALAF17
|
stationary phase, 330 minutes, 1 |
PALAF18
|
stationary phase, 330 minutes, 2 |
PALAF19
|
stationary phase, 480 minutes, 1 |
PALAF20
|
stationary phase, 480 minutes, 2 |
PALAF21
|
stationary phase, 720 minutes, 1 |
PALAF22
|
stationary phase, 720 minutes, 2 |
PALAF23
|
heat shock, 50 degrees, 10 minutes, 1 |
PALAF24
|
acid shock, pH2, 10 minutes, 1 |
PALAF25
|
acid shock, pH2, 10 minutes, 2 |
PALAF26
|
ciprofloxacin 20 ng/ml, 10 minutes, 1 |
PALAF27
|
ciprofloxacin 20 ng/ml, 30 minutes, 1 |
PALAF28
|
crp (b3357)::Tn5 mutant, 1 |
PALAF29
|
crp (b3357)::Tn5 mutant, 2 |
PALAF30
|
crp (b3357)::Tn5 mutant, 3 |
PALAF31
|
cspA (b3556)::Tn5 mutant, 1 |
PALAF32
|
dps (b0812)::Tn5 mutant, 1 |
PALAF33
|
dps (b0812)::Tn5 mutant, 2 |
PALAF34
|
dps (b0812)::Tn5 mutant, 3 |
PALAF35
|
dps (b0812)::Tn5 mutant, stationary phase, 240 minutes,
1 |
PALAF36
|
dps (b0812)::Tn5 mutant, stationary phase, 240 minutes,
2 |
PALAF37
|
dps (b0812)::Tn5 mutant, stationary phase, 480 minutes,
1 |
PALAF38
|
hns (b1237)::Tn5 mutant, 1 |
PALAF39
|
hns (b1237)::Tn5 mutant, 2 |
PALAF40
|
hns (b1237)::Tn5 mutant, 3 |
PALAF41
|
hupB (b0440)::Tn5 mutant, 1 |